slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 9,151-9,180
Pages 3,950
Rows per page 30
Component
9,151-9,180 of 118,471
129
The slide highlights the safety margin between the recommended dose (40mg) and the doses where QTc prolongation was observed (120-240mg), while noting specific patient populations at higher risk.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
149
The slide uses regulatory documents (EMA/FDA) and primary research (prescriber interviews) to build a case for potential safety risks.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
227
The slide highlights a discrepancy between the reported trial results and the underlying patient-level data regarding dosage and efficacy.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
241
The slide uses red text for emphasis on specific criticisms (dose response, centre effect).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
270
Includes verbatim Q&A excerpts highlighting patient volume and discontinuation rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
278
The slide uses a Q&A format to present qualitative feedback from a specific physician.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
340
The slide uses a Q&A format to highlight the discrepancy between industry standards and Harmony's practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
345
The slide uses a Q&A format to document testimony regarding corporate fraud and off-label promotion.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
350
The slide uses highlighted text to emphasize key admissions of fraudulent behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
356
The slide uses Q&A format to present expert testimony regarding potential regulatory violations and mismanagement.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
359
The slide uses a Q&A format to validate the thesis that high-volume prescribers quickly exhaust their patient pool and face insurance hurdles, contradicting potential growth narratives.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 4 hits
25
The slide presents Q&A style evidence to undermine the market perception of Lasertec's equipment utility.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularities4 hits
28
The slide uses a Q&A format to highlight the lack of independent validation for the A300 and suggests the 'exchange' offer is a way to mask the obsolescence of the A150.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularities4 hits
68
The slide uses the Toshiba accounting scandal as a precedent to critique inventory valuation practices, specifically mentioning Lasertec as a potential practitioner of similar methods.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Loop · The Reveal4 hits
117
The slide uses a Q&A format and direct quotes from former field engineers to substantiate claims of equipment failure.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
118
The slide presents a Q&A style interview excerpt highlighting product reliability issues and the scale of support staff required.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
123
The slide consists of two distinct blocks of text, each attributed to an expert in extreme ultraviolet lithography, detailing Intel's shifting narrative on supplier quality.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
131
The slide uses a Q&A format to validate claims about the unreliability and high maintenance costs of the light source.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
138
The slide uses a quote from a former KLA executive to frame the technical and strategic failure of Lasertec's stage procurement.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
163
The slide contrasts a product announcement with expert skepticism regarding its actual shipment status and technical readiness.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
174
The slide presents a series of critical testimonials/quotes from a subject matter expert to undermine the credibility of a specific technology (Isteq's Urashima light source).Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
177
The slide uses a series of quotes and Q&A snippets to undermine the credibility of Lasertec's 'newly designed' claims.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
187
The slide presents testimony from a former KLA executive to undermine Lasertec's market position by highlighting technical failures and customer dissatisfaction.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
188
The slide uses a Q&A format to expose the failure of Lasertec's equipment to support pellicle-based inspection, leading to yield loss and customer dissatisfaction.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
205
The slide presents a narrative of failure regarding Lasertec's equipment adoption at TSMC, citing four anonymous industry experts.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
211
The slide presents a Q&A format to highlight negative feedback from an industry insider regarding product reliability.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
248
The slide presents a Q&A format highlighting financial and operational strain caused by technical failures.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
264
The slide presents qualitative evidence (expert quotes) to establish a '1 unit per 5 ASML machines' ratio for market sizing.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
274
The slide presents qualitative evidence from industry experts to validate the thesis that KLA has the resources and technical capability to challenge Lasertec.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits
277
The slide presents qualitative evidence in the form of Q&A and direct quotes to support the thesis that customers want KLA to compete with Lasertec.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 4 hits